Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray B Urowitz

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
The Journal of Rheumatology|May 3, 2013
Systemic lupus erythematosus disease activity index 2000 responder index-50 websiteZahi Touma, Murray B Urowitz, Dafna D Gladman
The Journal of Rheumatology|February 3, 2019
Atherosclerotic Vascular Events in Systemic Lupus Erythematosus: An Evolving StoryMurray B Urowitz, Jiandong Su, Dafna D Gladman
The Journal of Rheumatology|September 11, 2003
Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupusDominique Ibañez, Murray B Urowitz, Dafna D Gladman
The Journal of Rheumatology|February 13, 2002
Systemic lupus erythematosus disease activity index 2000Dafna D Gladman, Dominique Ibañez, Murray B Urowitz
Current Opinion in Rheumatology|February 2, 2013
Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaignZahi Touma, Dafna D Gladman, Murray B Urowitz
Seminars in Arthritis and Rheumatism|November 13, 2018
How can we define low disease activity in systemic lupus erythematosus?Konstantinos Tselios, Dafna D Gladman, Murray B Urowitz
The Journal of Rheumatology|November 23, 2006
Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factorsMurray B Urowitz, Dominique Ibañez, Dafna D Gladman
Current Rheumatology Reports|August 21, 2009
Epidemiology of atherosclerosis in systemic lupus erythematosusMandana Nikpour, Murray B Urowitz, Dafna D Gladman
Open Access Rheumatology : Research and Reviews|January 6, 2017
Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategiesKonstantinos Tselios, Dafna D Gladman, Murray B Urowitz
Lupus Science & Medicine|August 25, 2015
Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II studyMurray B Urowitz, David A Isenberg, Daniel J Wallace
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
The Journal of Rheumatology|May 3, 2013
Systemic lupus erythematosus disease activity index 2000 responder index-50 websiteZahi Touma, Murray B Urowitz, Dafna D Gladman
The Journal of Rheumatology|February 3, 2019
Atherosclerotic Vascular Events in Systemic Lupus Erythematosus: An Evolving StoryMurray B Urowitz, Jiandong Su, Dafna D Gladman
The Journal of Rheumatology|September 11, 2003
Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupusDominique Ibañez, Murray B Urowitz, Dafna D Gladman
The Journal of Rheumatology|February 13, 2002
Systemic lupus erythematosus disease activity index 2000Dafna D Gladman, Dominique Ibañez, Murray B Urowitz
Current Opinion in Rheumatology|February 2, 2013
Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaignZahi Touma, Dafna D Gladman, Murray B Urowitz
Seminars in Arthritis and Rheumatism|November 13, 2018
How can we define low disease activity in systemic lupus erythematosus?Konstantinos Tselios, Dafna D Gladman, Murray B Urowitz
The Journal of Rheumatology|November 23, 2006
Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factorsMurray B Urowitz, Dominique Ibañez, Dafna D Gladman
Current Rheumatology Reports|August 21, 2009
Epidemiology of atherosclerosis in systemic lupus erythematosusMandana Nikpour, Murray B Urowitz, Dafna D Gladman
Open Access Rheumatology : Research and Reviews|January 6, 2017
Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategiesKonstantinos Tselios, Dafna D Gladman, Murray B Urowitz
Lupus Science & Medicine|August 25, 2015
Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II studyMurray B Urowitz, David A Isenberg, Daniel J Wallace
Pageof 19